Seattle’s newest unicorn: Truveta lands $320M to fuel creation of massive new genome project
The Truveta team at its Bellevue, Wash., headquarters last year. (Truveta Photo) Seattle-area health data company Truveta ...
Pharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers
The Fortune 500 pharma giant will sequence the exomes of 10 million people, with the goal of developing new therapies and ...
FierceBiotech4d
JPM25: Regeneron, Illumina and more back Truveta for 10M genome sequencing project
Illumina and Regeneron are taking stakes in health data company Truveta to help fund research that may dwarf the efforts of ...
STAT4d
Truveta enlists health systems, drugmakers to launch ambitious new genomic database
Health data company Truveta is partnering with health systems and drugmakers to create a massive database of genetic data ...
GlobalData on MSN4d
Illumina and Regeneron invest $139.5m in Truveta to build largest genetic database
The Truveta Genome Project aims to establish the world’s largest and most diverse database of genetic information.
Modern Healthcare4d
Truveta sells $320M stake to providers, others for genome project
Seventeen health systems, including Advocate Health, CommonSpirit Health, Henry Ford Health, Northwell Health, Providence and ...
pharmaphorum4d
Regeneron, Illumina join $320m Truveta investment
The two companies, along with 17 US health systems, will collectively take a $320 million stake in Truveta, with Regeneron ...
Regeneron To Invest $119.5 Mln In Truveta's Financing Round, Launch Truveta Genome Project
(RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN), Monday announced a collaboration with software company Truveta, Inc. and its collective of U.S. healthy systems, offering a strategic investment of ...
Nasdaq4d
Regeneron and Truveta Announce Strategic Collaboration for the Truveta Genome Project, Aiming to Expand Genetic Database and Accelerate Drug Discovery
Regeneron collaborates with Truveta to expand a genomic database, investing $119.5 million to enhance genetics-based healthcare research. Regeneron's $119.5 million investment in Truveta's Series ...